Sapreme Technologies
Pre-clinicalSapreme is a preclinical-stage biotech company developing next-generation RNA therapeutics for patients with genetically driven diseases.
Founded
2017
Focus
AntibodiesBiologicsDrug Delivery
About
Sapreme is a preclinical-stage biotech company developing next-generation RNA therapeutics for patients with genetically driven diseases.
Funding History
2Total raised: $14.2M
Series A$11MYsios CapitalNov 15, 2022
Seed$3.2MBioGeneration VenturesSep 15, 2020
Company Info
TypePrivate
Founded2017
LocationUtrecht, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile